FDA Issues Approvable

Related by string. * FDAs . fda . Fda : Drug Administration FDA . Receives FDA Clearance . FDA MedWatch Adverse Event . FDA Orphan Drug / issueing . ISSUES . ISSUE . issues : Sports Illustrated Swimsuit Issue . Taxation Issues gives . Emerging Issues . completeness contacting issues / approvable : approvable letter . orBec R approvable . FDA approvable letter . Approvable Letter * *

Related by context. Frequent words. (Click for all words.) 67 FDA Accepts 64 Generic Version 64 Positive Opinion 61 Extended Release 60 Patient Enrollment 58 Blood Thinner 58 Drug Candidate 57 Complete Response 57 Intent LoI 57 Low Dose 57 Completes Enrollment 56 Clinical Trial Results 56 Cholesterol Drug 56 Drug Makers 56 Patent Covering 56 Product Characteristics 56 Diet Pill 56 Teva Pharma 55 Paragraph IV 55 FDA Clears 55 Patent Infringement Lawsuit 54 Shareholder Letter 54 Javelin Pharmaceuticals 54 FDA Clearance 54 Pulmonary Arterial Hypertension 54 FDA Warns 54 Drug Application 54 Hormone Therapy 54 FDA Approval 53 Prostate Cancer Treatment 53 Option Grants 53 Full Prescribing Information 53 Regains Compliance 53 Receives CE 53 Marketing Authorization 53 Cold Medicines 53 Exclusive License 53 Company Nasdaq PRGO 53 submitted Biologics License 52 Patent Infringement Case 52 BioDelivery Sciences 52 FDA Orphan Drug 52 Anika Therapeutics 51 Flu Vaccines 51 Citizen Petition 51 Prescribing Information 51 submitted Marketing Authorization 51 Issues Guidance 51 Commercialization Agreement 51 Panel Rejects 51 Patent Lawsuit 51 Anthrax Vaccine 51 editor letters@smdailyjournal.com 50 Application MAA 50 Completes Tender Offer 50 Voluntary Recall 50 Director Shareholding 50 Boxed Warning 50 Extends Tender Offer 50 Resp 49 Bird Flu Vaccine 49 Receives Notice 49 Staff Deficiency Letter 49 Transmittal dated 49 Provides Guidance 49 FDA approvable letter 49 Commence Trading 49 EPIX Pharmaceuticals 49 Continued Listing 49 FY# Guidance 49 BioMarin develops 49 Paragraph IV certification 49 Final Approval 48 Act PDUFA date 48 Shareholder Vote 48 Q2 Loss Narrows 48 Issues Statement Regarding 48 Medicis Pharmaceutical Corporation 48 Symbol Change 48 FDA Advisory Panel 47 Shareholder Approval 47 Non Compliance 47 Protopic 47 Intent LOI 47 Combidex 47 Position Statement 47 Fast Track Designation 47 pSivida Limited 47 Warning Letter 47 Swine Flu Vaccine 47 Approvable Letter 47 Q2 Loss Widens 47 By MICHAEL RADANO 47 orphan designation 47 Enters Into Letter 47 Marketing Authorization Application 47 Complete Response Letter 47 NASDAQ Listing 46 binding Letter 46 Sunesis Pharmaceuticals 46 By RENEE WINKLER

Back to home page